文献速递临床试验与 GCP

机器人自然腔道取标本手术与传统机器人辅助手术治疗结直肠癌:随机对照试验研究方案

Robotic natural orifice specimen extraction surgery versus traditional robotic-assisted surgery (NOTR) for patients with colorectal cancer: a study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2021-02-06

本研究为前瞻性、开放标签、随机对照、平行组、多中心非劣效性试验,计划纳入550例结直肠癌患者,比较机器人自然腔道取标本手术(NOSES)与传统机器人辅助手术的安全性及有效性。主要结局为手术并发症发生率,采用Clavien-Dindo系统分级,非劣效界值设为10%,单侧显著性水平0.025,把握度80%。

要点

  • 机器人NOSES旨在减少腹部切口,评估其非劣效于传统机器人辅助手术。
  • 主要结局为手术并发症发生率,采用Clavien-Dindo系统分类。
  • 计划样本量550例,非劣效界值10%,单侧α=0.025,把握度80%。

核心结论

  • 该试验旨在验证机器人NOSES在结直肠癌患者中是否非劣效于传统机器人辅助手术。

研究设计与样本

  • 前瞻性、开放标签、随机对照、平行组、多中心非劣效性试验,计划纳入550例结直肠癌患者。

关键数值与推荐

  • 主要结局为手术并发症发生率,采用Clavien-Dindo系统分级。
  • 非劣效界值为10%,单侧显著性水平0.025,把握度80%。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Natural orifice specimen extraction surgery for colorectal cancer has been introduced in order to reduce the abdominal incision, demonstrating major development potential in minimally invasive surgery. We are conducting this randomized controlled trial to assess whether robotic NOSES is non-inferior to traditional robotic-assisted surgery for patients with colorectal cancer in terms of primary and secondary outcomes. METHOD/DESIGN: Accordingly, a prospective, open-label, randomized controlled, parallel-group, multicenter, and non-inferiority trial will be conducted to discuss the safety and efficacy of robotic natural orifice extraction surgery compared to traditional robotic-assisted surgery. Here, 550 estimated participants will be enrolled to have 80% power to detect differences with a one-sided significance level of 0.025 in consideration of the non-inferiority margin of 10%. The primary outcome is the incidence of surgical complications, which will be classified using the Clavien-Dindo system. DISCUSSION: This trial is expected to reveal whether robotic NOSES is non-inferior to traditional robotic-assisted surgery, which is of great significance in regard to the development of robotic NOSES for patients with colorectal cancer in the minimally invasive era. Furthermore, robotic NOSES is expected to exhibit superiority to traditional robotic-assisted surgery in terms of both primary and secondary outcomes. TRIAL REGISTRATION: ClinicalTrials.gov NCT04230772 . Registered on January 15, 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Luo R, Zheng F, Zhang H, et al. Robotic natural orifice specimen extraction surgery versus traditional robotic-assisted surgery (NOTR) for patients with colorectal cancer: a study protocol for a randomized controlled trial. Trials. 2021. PMID: 33549133. doi:10.1186/s13063-021-05077-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。